Trxade Group Inc. (MEDS) |
|
5.87 -0.11 (-1.84%)
|
01-17 16:40 |
|
Open: |
6 |
Pre. Close: |
5.98 |
|
High:
|
6.09 |
Low:
|
5.7 |
|
Volume:
|
116,644 |
Market Cap:
|
48M |
|
|
|
|
Trxade Group, Inc., together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, a web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, an application, which offers product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics; and Bonum+, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools. Trxade Group, Inc. is based in Land O'Lakes, Florida. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.099 - 6.13 |
6.13 - 6.155 |
|
Low:
|
5.632 - 5.663 |
5.663 - 5.689 |
|
Close:
|
5.823 - 5.873 |
5.873 - 5.914 |
|
Technical analysis |
as of: 2021-01-15 4:42:59 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 7.29 One year: 8.51 |
| Support: |
Support1: 5.57 Support2: 5.15 |
| Resistance: |
Resistance1: 6.24 Resistance2: 7.29 |
| Pivot: |
5.54  |
| Moving Average: |
MA(5): 5.82 MA(20): 5.49
MA(100): 5.46 MA(250): 5.55 |
| MACD: |
MACD(12,26): 0.14 Signal(9): 0.09 |
| Stochastic oscillator: |
%K(14,3): 62.78 %D(3): 65.60 |
| RSI: |
RSI(14): 59.14 |
| 52-week: |
High: 11.60 Low: 1.18 Change(%): 373.4 |
| Average Vol(K): |
3-Month: 72418 10-Days: 10974 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MEDS has closed below upper band by 12.1%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 07 Jan 2021
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary - AlphaStreet
Fri, 04 Dec 2020
Is Trxade Group Inc (MEDS) Stock About to Get Hot Friday? - InvestorsObserver
Wed, 18 Nov 2020
TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational - GlobeNewswire
Tue, 17 Nov 2020
Should You Buy Trxade Group Inc (MEDS) Stock After it Is Down 21.80% in a Week? - InvestorsObserver
Tue, 10 Nov 2020
TRxADE Group to Present at the Virtual Fall Investor Summit - GlobeNewswire
Mon, 26 Oct 2020
Trxade Group Reports Record Third Quarter 2020 Financial Results - GlobeNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Pharmaceutical Retailers |
| Shares Out. (M) |
8 |
| Shares Float (M) |
3 |
|
% Held by Insiders
|
61.34 |
|
% Held by Institutions
|
14.06 |
|
Shares Short (K)
|
214 |
|
Shares Short P. Month (K)
|
79 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
-4.27 |
|
Operating Margin
|
-1.13 |
|
Return on Assets (ttm)
|
-1.3 |
|
Return on Equity (ttm)
|
-9.8 |
|
Qtrly Rev. Growth
|
174.0 |
|
Gross Profit (p.s.)
|
0.602 |
|
Sales Per Share
|
2.079 |
|
EBITDA (p.s.)
|
-0.023 |
|
Qtrly Earnings Growth
|
402.10 |
|
Operating Cash Flow (M)
|
-2 |
|
Levered Free Cash Flow (M)
|
-1 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
2.82 |
|
Price to Cash Flow
|
-28.27 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
